Clinical Trial: Group Therapy for Postpartum Depression

This study is currently recruiting patients.

Sponsored by: National Institute of Mental Health (NIMH)
Information provided by: National Institute of Mental Health (NIMH)

Purpose

The purpose of this study is to examine the efficacy of a mother-infant relational group therapy approach for postpartum depression by comparing it to a standard individual treatment approach.

Condition Treatment or Intervention
Depression, Postpartum
 Behavior: Mother-Infant Psychotherapy
 Behavior: Interpersonal Psychotherapy

MedlinePlus related topics:  Postpartum Depression

Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind, Active Control, Parallel Assignment, Efficacy Study

Official Title: Relational Group Intervention for Postpartum Depression

Further Study Details: 

Expected Total Enrollment:  208

Study start: January 2002

Ten to twenty percent of new mothers experience major depression in the postpartum period or postpartum depression (PPD). This condition poses a risk for disturbances in the mother-infant relationship as well as for developmental delays and subsequent psychopathology in their children. Thus, and investigation of the efficacy of a relational approach that focuses on improving the mother's sense of competence in the parenting role, and reducing depressive symptoms and social isolation through group therapy is warranted.

Patients are randomly assigned to either relational group treatment or to standard individual treatment. Assessments of maternal and infant functioning, mother-infant and father-infant relations, parenting stress, and marital conflict and conducted pre- and post-treatment, at 12 months post-treatment, and when infants are 12 and 24 months of age.

Eligibility

Ages Eligible for Study:  18 Years and above,  Genders Eligible for Study:  Female

Criteria

Inclusion Criteria:

  • Major depression with an infant under 7 months of age

Exclusion Criteria:

  • Bipolar disorder
  • Schizophrenia
  • Organic brain syndrome
  • Antisocial personality disorder
  • Current psychosis or mania
  • Lifetime history of mental retardation
  • Current alcohol or substance abuse
  • Cognitive disability
  • Infants born more than 6 weeks premature or with major medical conditions or developmental disabilities

Location and Contact Information

Roseanne Clark, PhD      608-263-6067    rclark@wisc.edu

Wisconsin
      Univ. of Wisconsin Dept. of Psychiatry, Madison,  Wisconsin,  53719,  United States; Recruiting
Roseanne Clark, Ph.D.  608-263-6067    rclark@wisc.edu 
Kathleen Hipke, PhD  608-263-6123    khipke@wisc.edu 

More Information

Study ID Numbers:  62054-01A1
Record last reviewed:  January 2005
Last Updated:  January 12, 2005
Record first received:  January 7, 2003
ClinicalTrials.gov Identifier:  NCT00051246
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08


Source: ClinicalTrials.gov
Cache Date: April 9, 2005